Hexane and Neurodegenerative Disease: Why European Neurologists Are Concerned

Concern is growing among European neurologists about a widely used petrochemical solvent, hexane, which they associate with the increasing prevalence of neurodegenerative diseases. They argue that the food sector can no longer overlook the warning signals.

What is hexane and why it matters to your plate

Hexane is a transparent, extremely volatile liquid produced from crude oil. Its principal industrial role is as a solvent. Food-processing plants use it to extract oil from seeds, including soya, rapeseed and sunflower, at very large volumes. As the method increases output and lowers costs, it has become the worldwide norm.

At many European processing sites, crushed seeds are soaked in hexane. The solvent removes the fat before being evaporated with heat. Rules stipulate that virtually all residues must be removed before the oil reaches supermarket shelves or is used in processed food. However, a threshold close to zero still permits trace quantities, which critics regard as a gap in public-health policy.

Traces of industrial solvents in everyday food raise questions at a time when neurodegenerative diseases are surging across ageing populations.

Food producers maintain that existing safety thresholds protect the public. They note that regulatory bodies based permitted limits on the toxicological evidence available when those limits were established. Much of that evidence examined immediate toxicity and clear organ damage rather than subtle effects on the brain that may take decades to emerge.

The neurologist who sees too many patients too soon

Neurologist David Devos has spent much of his working life treating people with Parkinson’s disease in northern France. At Lille University Hospital, he receives a steady stream of new patients. Many are younger than anticipated and have symptoms that affect their employment, family lives and independence.

Devos became recognised for a technical development: a pump that administers dopamine directly into the brain via a catheter. Conventional tablets can become less effective as Parkinson’s progresses. The continuous, precisely directed infusion he developed is intended to steady symptoms and lessen debilitating fluctuations.

Initial research indicates that intracerebral dopamine perfusion may improve motor control more effectively than standard oral treatments for certain patients. A larger clinical trial is scheduled for around 2026 to validate those findings and identify more clearly which patients benefit most. For Devos, this work addresses the pressing requirements of people who are already living with the disease.

However, the continual arrival of new Parkinson’s cases led him to investigate earlier causes. Why are so many brains degenerating at all? Why do certain regions and occupations carry greater risks? These questions prompted him and fellow specialists to reconsider chemicals that move unnoticed through workplaces and food chains.

Hexane and the brain: what current science suggests

Within the body, hexane is broken down into several metabolites, including 2,5-hexanedione, the best-known derivative of n-hexane. This substance can harm peripheral nerves, leading to numbness, burning feelings and muscle weakness. Occupational medicine has recorded such cases for decades among workers exposed to high levels in poorly ventilated facilities.

Neurotoxicity from hexane is not a theoretical risk; it is well established in exposed workers. The unresolved question is where the lower, chronic threshold truly lies.

Scientists are now examining whether prolonged low-level exposure, including exposure through food and indoor air, may play a part in neurodegenerative illnesses affecting the central nervous system. Laboratory findings show that hexane metabolites can interfere with axons, the long structures through which neurons communicate. Harm to these structures may gradually weaken entire neural networks.

Population research is limited and is frequently lacking in precision. Exposure commonly involves a combination of solvents, pesticides and metals. Nevertheless, several case-control studies suggest higher rates of Parkinson’s among people who have spent long careers in agriculture, food processing, printing or manufacturing industries where solvents are extensively used.

For specialists such as Devos, these overlapping indications support a precautionary change, particularly when safer alternatives are already available. They emphasise that the brain ages over many decades and that repeated minor impacts may build into a substantial risk.

How hexane slips into daily life

From seed to shelf

Most people are unaware of hexane when buying an inexpensive bottle of vegetable oil or margarine. Product labels generally state only “vegetable oils” or name the relevant seeds. The industrial process behind these goods often follows the same sequence:

• Seeds are delivered to a crushing plant and pressed mechanically.
• The seed cake left behind still contains a considerable quantity of fat.
• Hexane is passed through this cake to remove more oil.
• The solvent is heated, recovered and used again, while trace residues remain in the crude oil.
• The oil is then refined, deodorised and bottled.

Regulations generally specify maximum permitted hexane residue levels in food oils. Checks assess random samples, although testing frequency and the openness of published results differ between countries. Shoppers seldom have access to this information.

Other discreet sources of exposure

Hexane is also found outside the food chain, in adhesives, aerosols, shoe production, furniture finishing and certain cleaning products. Fumes may be inhaled at home or at work, particularly in confined areas with poor ventilation.

Context	Typical use of hexane	Main route of exposure
Edible oil production	Solvent for seed oil extraction	Residues in oils and processed foods
Industrial manufacturing	Adhesives, degreasing, formulations	Inhalation in workplaces
Domestic products	Some sprays, glues, DIY products	Indoor air and skin contact

Any one of these sources may represent a relatively limited exposure. Together, however, they could create a background level that present regulations undervalue, especially for those facing additional risk factors such as pesticides or heavy metals.

Calls to phase out hexane from the food chain

Media coverage in France and other countries has intensified in recent months as neurologists, toxicologists and environmental organisations call for hexane to be phased out of agri-food production. In a frequently referenced opinion piece, Devos and his colleagues called on governments to view the solvent as a preventable contributor to brain disease rather than merely an industrial technicality.

For clinicians on the front line of Parkinson’s and other neurodegenerative disorders, cutting avoidable neurotoxic exposures has become a form of preventive medicine.

Supporters of a phase-out say mechanical pressing technologies can already meet a substantial portion of vegetable oil demand. Although the yield per tonne of seeds is slightly lower, the finished product often has a stronger nutritional profile and a shorter, more transparent manufacturing route. They also cite increasing demand for “first cold-pressed” and “expeller-pressed” labels, which generally signify processing without solvents.

Industry representatives respond that an abrupt prohibition could raise prices, damage export competitiveness and put pressure on supply chains for processed products, from biscuits to plant-based meat alternatives. They want regulators to await more conclusive epidemiological evidence before requiring expensive changes.

This political discussion lies where health, trade and climate policy meet. Solvent-based extraction produces the highest possible oil yield from every hectare, fitting prevailing agricultural economics. On the other hand, reducing petrochemical inputs supports wider efforts to decarbonise food systems and lessen dependence on fossil fuels.

What consumers can already do

While politicians debate and scientists collect further evidence, people can still take steps to limit possible exposure without radically changing their diets. No measure guarantees complete safety, but these choices generally shift consumption away from highly processed products dependent on solvents.

• Choose mechanically pressed or “cold-pressed” oils where finances permit.
• Prepare meals from whole foods more often instead of relying on ultra-processed products high in cheap refined fats.
• Air kitchens and work areas, particularly when using sprays or powerful adhesives.
• Reduce indoor use of solvent-based DIY products, or use protective equipment.
• Observe occupational-health requirements in roles involving solvents.

As well as reducing theoretical exposure to hexane, these practices are consistent with wider guidance on metabolic and cardiovascular health, both of which affect brain ageing.

Why neurodegenerative risk goes beyond one solvent

A focus on hexane alone may appear restrictive. Specialists stress that Parkinson’s, Alzheimer’s and similar conditions seldom result from one cause. Genetics, air pollution, pesticides, head injuries, lifestyle and ageing all interact. Yet solvents are among the factors that can be controlled comparatively quickly through policy.

When developing public-health scenarios, researchers often consider the consequences of removing several environmental risks simultaneously. Reducing contact with a group of substances that harm neurons, rather than waiting for definitive proof against every individual substance, could alter disease trends during the next two or three decades.

This reasoning is based on the idea of cumulative burden. A brain exposed to low doses of multiple neurotoxic agents-solvents, heavy metals and pesticides-may reach a critical threshold earlier than one exposed to only a single agent. This view encourages regulators to assess group restrictions and conduct longer-term monitoring of exposed communities.

At present, the debate around hexane offers a tangible test: how much uncertainty are governments prepared to tolerate when neurotoxicity is established but precise long-term evidence for the wider population remains incomplete? The outcome will influence food-industry methods as well as the neurological health of ageing societies in the future.